Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults (HT)
The overall objectives are to:
- Assess mechanisms underlying HIIT-induced improvements in insulin resistance at the whole-body, tissue, and cellular levels.
- Systematically compare different HIIT regimens to help identify effective "doses" of HIIT that may be optimal for improving metabolic health in obese adults.
- Assess the ability/willingness of obese subjects to adhere to a long-term HIIT program.
Findings from these studies will greatly expand knowledge about the effects of HIIT on metabolic health, and will provide valuable information for development of programs aimed at maximizing key metabolic benefits of exercise.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48178
- Suzette Howton
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 18-40
- Body Mass Index: 30-40 kg/m2
- Waist circumference: 88-98cm for women and 100-110cm for men
- No regularly planned exercise/physical activity
- Women must have regularly occurring menses and must be premenopausal
Exclusion Criteria:
- EKG abnormalities as assessed by the cardiologist on the research team
- Evidence/history of cardiovascular or metabolic disease
- Medications known to affect lipid or glucose metabolism
- Pregnant or lactating
- Tobacco or e-cigarette use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: High Intensity Interval Training (HIIT)
Obese adults with impaired glucose tolerance will be randomized into one of two different exercise training groups for a 3 month exercise intervention.
|
(HIIT) 10 x 1 min.
at ~90%HRmax - with low intensity warm-up, recovery, and cool down - total of 25 min/session .
|
|
Other: Moderate intensity continuous training (MICT)
Obese adults with impaired glucose tolerance will be randomized into one of two different exercise training groups for a 3 month exercise intervention.
|
Moderate-intensity continuous training (MICT) = steady-state exercise at 60-70%HRmax for 45min.
Representing a commonly prescribed exercise program.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin Sensitivity
Time Frame: Change from Baseline after 3 months of exercise training
|
A hyperinsulinemic-euglycemic clamp was used to assess peripheral insulin sensitivity.
Briefly, a primed, continuous infusion of insulin (40 mU/m^2/min) was administered; blood glucose was assessed every 5 minutes and 20% dextrose (D20 enriched with [6-6 d2]glucose) was infused at a variable rate to accommodate changes in blood glucose in order to maintain blood glucose at the participants' overnight fasted levels.
About 2 hours after beginning the insulin infusion, when blood glucose concentration stabilized without further changes in the rate of D20 infusion for ≥ ~20 minutes, arterialized blood samples were collected every 5 minutes during the final 20 minutes of the clamp for the determination of steady state tracer-labeled glucose enrichment in plasma to calculate the rate of glucose disposal.
|
Change from Baseline after 3 months of exercise training
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VO2peak
Time Frame: Change from Baseline after 3 months of exercise training
|
Change in aerobic capacity between baseline and after 3 months of training
|
Change from Baseline after 3 months of exercise training
|
|
Resting Metabolic Rate
Time Frame: Change from Baseline after 3 months of exercise training
|
energy expenditure while at rest
|
Change from Baseline after 3 months of exercise training
|
|
Hepatic Fat %
Time Frame: Change from Baseline after 3 months of exercise training
|
Change in abundance of fat in the liver - reported as % area (measured by MRI)
|
Change from Baseline after 3 months of exercise training
|
|
Visceral Fat Area (cm^2)
Time Frame: Change from Baseline after 3 months of exercise training
|
Change in fat accumulation in the visceral region - measured by MRI
|
Change from Baseline after 3 months of exercise training
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jeff Horowitz, University of Michigan
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Metabolic Diseases
- Glucose Metabolism Disorders
- Hyperglycemia
- Nutritional and Metabolic Diseases
- Glucose Intolerance
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Physical Conditioning, Human
- Exercise
- High-Intensity Interval Training
Other Study ID Numbers
Other Study ID Numbers
- HUM00106883
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.